HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy. (Q42201273)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 August 2014

edit

Language	Label	Description	Also known as
English	HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy.	scientific article published on 28 August 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

title

HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

author

Tetsuya Hosaka

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Hiromitsu Kumada

series ordinal

13

object named as

Hiromitsu Kumada

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Fumitaka Suzuki

series ordinal

2

object named as

Fumitaka Suzuki

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Kenji Ikeda

series ordinal

11

object named as

Kenji Ikeda

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Masahiro Kobayashi

series ordinal

3

object named as

Masahiro Kobayashi

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Yoshiyuki Suzuki

series ordinal

8

object named as

Yoshiyuki Suzuki

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Norio Akuta

series ordinal

7

object named as

Norio Akuta

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Yasuji Arase

series ordinal

10

object named as

Yasuji Arase

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Hitomi Sezaki

series ordinal

6

object named as

Hitomi Sezaki

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Satoshi Saito

series ordinal

9

object named as

Satoshi Saitoh

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Yusuke Kawamura

series ordinal

5

object named as

Yusuke Kawamura

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

Mariko Kobayashi

series ordinal

12

object named as

Mariko Kobayashi

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

author name string

Taito Fukushima

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

publication date

28 August 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

published in

Liver International

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

page(s)

1290-1302

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

cites work

Viral hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Chronic hepatitis B virus infection in Asian countries

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Telbivudine versus lamivudine in patients with chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FLIV.12652

retrieved

21 January 2018

Identifiers

DOI

10.1111/LIV.12652

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

PubMed publication ID

25103089

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25103089

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25103089%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 March 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42201273&oldid=1760906304"